The first safe, non-invasive wireless power platform for high power medical devices like ventricular assist devices and total artificial hearts.
Cardessa™ High
Power Platform
Cardessa™: High Power Platform
Cardessa™ is a high-power wireless energy transfer platform for implantable medical devices, delivering up to 15 watts of continuous power. Designed for applications such as left ventricular assist devices (LVADs), total artificial hearts (TAHs), and other high-power implants, Cardessa™ enables fully implantable systems by eliminating the transcutaneous driveline that causes complications and limits quality of life.
Improve outcomes and quality of life for patients living with high power implantables
10-15 W
10-15 W wireless power to eliminate drivelines
6 cm
6 cm misalignment with high tilt tolerance so patients can move while charging
3 cm
3 cm deep implants to treat more body types and more precisely
Wireless charging platform for high power implantable medical devices
Improve outcomes and quality of life for patients living with high power implantables.
How Resonant Link Medical and Abbott went from impossible to a path forward in nine months
Learn how Resonant Link Medical and Abbott tackled one of the biggest challenges in medical device design and power: how to safely recharge left ventricular assist devices from outside of the body, to get rid of drivelines and help patients with advanced heart failure live life to the fullest.
Safe, non-invasive wireless power for VADs and TAHs
Deliver 10-15 W to power implants without drivelines
Free patients to move around while charging with greater misalignment and real-time charge control
Safely recharge the implanted battery from outside the body
Explore our other implantable power platforms
.webp)
Eterni™ for Tiny Implants
Up to 500 mW continuous wireless power or recharging for mm-size implants.
Vivigo™ Fast Charger
20-minute wireless charging over a large range to improve compliance, clinical outcomes, and adoption.
Frequently asked questions
Contact Us
Yes. Resonant Link Medical's Cardessa™ High Power Platform delivers 10 to 15 watts of wireless power, sufficient to support left ventricular assist devices (LVADs) and total artificial hearts (TAH) without a percutaneous driveline. Driveline elimination removes the primary infection risk associated with long-term mechanical circulatory support, which is a leading cause of morbidity in LVAD patients. The Cardessa™ platform enhances patient mobility by enabling fully implanted operation, improving quality of life and therapy adherence.
A driveline is a cable that passes through the skin connecting a left ventricular assist device’s (LVAD’s) internal pump to an external power controller. While effective, percutaneous drivelines create a permanent wound that is susceptible to infection. Driveline infections are a major cause of hospitalization and mortality in LVAD patients. Transcutaneous energy transfer systems, or wireless power systems, like Resonant Link Medical's Cardessa™ platform eliminate the driveline entirely, allowing the device to operate from power delivered through intact skin.